776
Participants
Start Date
November 30, 2003
Primary Completion Date
July 31, 2007
Study Completion Date
July 31, 2007
HPV 16/18 VLP AS04
GSK Investigational Site, Pittsburgh
GSK Investigational Site, Philadelphia
GSK Investigational Site, Bardstown
GSK Investigational Site, Louisville
GSK Investigational Site, Marshfield
GSK Investigational Site, Houston
GSK Investigational Site, West Jordan
GSK Investigational Site, Salt Lake City
GSK Investigational Site, Albuquerque
GSK Investigational Site, San Francisco
GSK Investigational Site, Portland
GSK Investigational Site, Seattle
GSK Investigational Site, San Francisco
GSK Investigational Site, Augusta
GSK Investigational Site, Lebanon
GSK Investigational Site, Morristown
GSK Investigational Site, San Antonio
GSK Investigational Site, Curitiba
GSK Investigational Site, Porto Alegre
GSK Investigational Site, São Paulo
GSK Investigational Site, Campinas
GSK Investigational Site, Fortaleza
GSK Investigational Site, Edmonton
GSK Investigational Site, Langley
GSK Investigational Site, Winnipeg
GSK Investigational Site, St. John's
GSK Investigational Site, Toronto
Lead Sponsor
GlaxoSmithKline
INDUSTRY